The Latest
The WasteWatcherUSPTO-FDA Study Debunks Critics and Demonstrates the Importance of Protecting IP
USPTO-FDA study reinforces the need to protect pharmaceutical intellectual property rights for the future of new drug development.
State ActionCCAGW Urges North Carolina Senators to Oppose HB 246
HB 246 would impose onerous regulations on pharmacy benefit managers.
Letters to OfficialsCCAGW Joins Coalition Opposing Housing Price Controls
Nationwide rent controls and price controls will further inflate housing costs.
The WasteWatcherThe IRA Has Undermined Medicare Part D
The Inflation Reduction Act creates instability in the Medicare Part D Program.
Op-EdsEarmarks Jeopardize America's Water Infrastructure
Earmarks go disproportionately to members of the House and Senate appropriations committees and leadership and divert funds from needier communities to wealthier ones.
State ActionCCAGW Urges California Assembly to Oppose SB 966
SB 966 would insert the government further into the healthcare system and result in higher costs and fewer choices for patients in California.
Press ReleaseCitizens Against Government Waste Names Environmental Protection Agency Administrator Michael Regan August 2024 Porker of the Month
EPA Administrator Michael Regan has pushed for districts to purchase electric school buses.
The WasteWatcherNot-So-Happy Birthday to the Inflation Reduction Act
The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
The WasteWatcherCourt Further Delays Net Neutrality Implementation
On August 1, 2024, the U.S. Court of Appeals for the Sixth Circuit extended the stay on the FCC's latest net neutrality order.
The WasteWatcherFifth Circuit Determines the USF Fee Is a Tax
The Fifth Circuit Court rocked the telecommunications world when it released its ruling on funding the USF.
Agency CommentsCAGW Submits Comments on FTC's Interim Staff Report on PBMs
Overregulating PBMs will drive up prescription drug costs and be a disservice to the millions of patients that benefit from them.
The WasteWatcherNew Study Shows PBMs Lower Drug Prices
A new report challenges assertions made during the committee's recent hearing on the role of pharmacy benefit managers.
